Despite years of guidelines cautioning against their use, potentially inappropriate central nervous system (CNS)-active medications are commonly prescribed to older adults —particularly those with ...
Central nervous system (CNS) toxicity accounts for 25% of safety failures across drug discovery and development, yet it is rarely detected during standard GLP toxicology studies 1. Seizure risk ...
The blood-brain barrier functions as a tightly regulated biological filter, shielding brain tissue from harmful substances traveling through the bloodstream. While this defense mechanism is vital for ...
AUSTIN, Texas, May 11, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: The human brain remains one of the most protected, and difficult to treat, organs in the body. At the center of this ...
A new report published by the Tufts Center for the Study of Drug Development (CSDD) validates longstanding data indicating that drugs intended to treat disorders of Central Nervous System (CNS) take ...
Drug-loaded albumin NPs hijack calvarial immune cells to bypass the BBB via skull-meninges microchannels for CNS drug delivery and stroke therapy, establishing skull-based delivery and immune-assisted ...
SEOUL, South Korea, April 22, 2026 /PRNewswire/ -- ImmunoForge Co., Ltd., a clinical-stage biopharmaceutical company specializing in treatments for rare and muscular diseases, is poised to redefine ...
Drug Farm to Present Ophthalmologic and CNS Findings from Phase 1b Study of First-in-Class ALPK1 Inhibitor DF-003 in ROSAH Syndrome at ARVO 2026 Drug Farm today announced ophthalmologic and central ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results